In the latest trading session,, 5.36 million ZyVersa Therapeutics Inc (NASDAQ:ZVSA) shares changed hands as the company’s beta touched 0.62. With the company’s most recent per share price at $0.62 changed hands at -$0.06 or -8.16% at last look, the market valuation stands at $2.24M. ZVSA’s current price is a discount, trading about -980.65% off its 52-week high of $6.70. The share price had its 52-week low at $0.55, which suggests the last value was 11.29% up since then. When we look at ZyVersa Therapeutics Inc’s average trading volume, we note the 10-day average is 0.85 million shares, with the 3-month average coming to 2.28 million.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information
Instantly ZVSA was in red as seen in intraday trades today. With action -6.77%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -41.51%, with the 5-day performance at -6.77% in the red. However, in the 30-day time frame, ZyVersa Therapeutics Inc (NASDAQ:ZVSA) is 1.94% up. Looking at the short shares, we see there were 0.51 million shares sold at short interest cover period of 0.09 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 58.00%.
ZVSA Dividends
ZyVersa Therapeutics Inc is expected to release its next quarterly earnings report on 2024-Nov-13.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.17% of ZyVersa Therapeutics Inc shares while 2.24% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 2.24%.
Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . With 4.95 shares estimated at $3112.0 under it, the former controlled 0.14% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.08% of the shares, roughly 2.94 shares worth around $1850.0.
